Literature DB >> 17064783

MMP-2, VCAM-1 and NCAM-1 expression in the brain of rats with experimental autoimmune encephalomyelitis as a trigger mechanism for synaptic plasticity and pathology.

Katica Jovanova-Nesic1, Yehuda Shoenfeld.   

Abstract

The neural cell adhesion molecules (NCAMs), and vascular cell adhesion molecules (VCAMs) that regulate cell-to-extracellular matrix adhesion, and matrix metalloproteinases (MMPs), modulating the extracellular matrix (ECM), are considered to play an important role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE). Clinical signs appearance and significant increases of MMP-2 expression in CA1 and CA3 subdomains of the hippocampus and around the central canal of the cervical spinal cord, with the clusters of VCAM-1(+) immunoreactive cells localized in the choroid plexus epithelium and hypothalamo-hypophyses portal vessel system indicate an inflammation in acute EAE. Decreased NCAM-1 expression in CA1 and CA3 fields of the hippocampus, and in a lesser degree in the basal ganglia, limbic structure and cervical spinal cord, support the concept that the demyelinating neuroinflammatory damage in an autoimmune brain affect synaptic organization of the brain, altering the balance between extracellular proteases and cell adhesion molecules which appears to be critical for both the brain plasticity and autoimmune processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17064783     DOI: 10.1016/j.jneuroim.2006.08.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Cleavage of myelin associated glycoprotein by matrix metalloproteinases.

Authors:  Elizabeth Milward; Kee Jun Kim; Arek Szklarczyk; Thien Nguyen; Giorgia Melli; Mamatha Nayak; Deepa Deshpande; Chantel Fitzsimmons; Ahmet Hoke; Douglas Kerr; John W Griffin; Peter A Calabresi; Katherine Conant
Journal:  J Neuroimmunol       Date:  2007-12-11       Impact factor: 3.478

2.  Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.

Authors:  Marina O Ziehn; Andrea A Avedisian; Seema Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  Lab Invest       Date:  2010-02-15       Impact factor: 5.662

3.  Proteins Involved in Synaptic Plasticity Are Downregulated in the Cerebrospinal Fluid of Infants With Clinical Sepsis Complicated by Neuroinflammation.

Authors:  Ping-Ping Jiang; Shan-Shan Peng; Stanislava Pankratova; Ping Luo; Ping Zhou; You Chen
Journal:  Front Cell Neurosci       Date:  2022-05-11       Impact factor: 6.147

4.  Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.

Authors:  Antonio Drago; Barbara Monti; Diana De Ronchi; Alessandro Serretti
Journal:  Neuropsychobiology       Date:  2014-02-27       Impact factor: 2.328

5.  Matrix metalloproteinases, synaptic injury, and multiple sclerosis.

Authors:  Arek Szklarczyk; Katherine Conant
Journal:  Front Psychiatry       Date:  2010-10-05       Impact factor: 4.157

6.  From buds to follicles: matrix metalloproteinases in developmental tissue remodeling during feather morphogenesis.

Authors:  Ting-Xin Jiang; Tai Lan Tuan; Ping Wu; Randall B Widelitz; Cheng-Ming Chuong
Journal:  Differentiation       Date:  2011-04-17       Impact factor: 3.533

7.  Children With Autism Spectrum Disorder With Regression Exhibit a Different Profile in Plasma Cytokines and Adhesion Molecules Compared to Children Without Such Regression.

Authors:  Antonio Gomez-Fernandez; Maria J de la Torre-Aguilar; Mercedes Gil-Campos; Katherine Flores-Rojas; Maria D Cruz-Rico; Pilar Martin-Borreguero; Juan Luis Perez-Navero
Journal:  Front Pediatr       Date:  2018-09-26       Impact factor: 3.418

Review 8.  Proteolytic remodeling of the synaptic cell adhesion molecules (CAMs) by metzincins in synaptic plasticity.

Authors:  Malgorzata Bajor; Leszek Kaczmarek
Journal:  Neurochem Res       Date:  2012-11-04       Impact factor: 3.996

9.  Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.

Authors:  Su Zhang; Quan-Cheng Kan; Yuming Xu; Guang-Xian Zhang; Lin Zhu
Journal:  Mediators Inflamm       Date:  2013-09-08       Impact factor: 4.711

10.  miRNA-26a blocks interleukin-2-mediated migration and proliferation of non-small cell lung cancer cells via vascular cell adhesion molecule-1.

Authors:  Lifei Li; Di Li; Yongbiao Chen
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.